Search For "emergency use"
Pakistan approves emergency use of Oxford-AstraZeneca Covid-19 vaccine
Updated : 5 years, 4 months ago IST
Islamabad [Pakistan], January 16 (ANI): Pakistan granted approval for the emergency use of Oxford-AstraZeneca's Covid-19 vaccine on Saturday.
Read More
Manish Tewari criticises vaccination drive, questions efficacy of vaccines
Updated : 5 years, 4 months ago IST
New Delhi [India], January 16 (ANI): As the nationwide vaccination drive commenced on Saturday, Congress Member of Parliament Manish Tewari raised questions on the efficacy and safety of both COVID-19 vaccines approved for emergency use in the country.
Read More
After approval of Covishield vaccine, Nepal residents hope Covid-19 pandem
Updated : 5 years, 4 months ago IST
Kathmandu [Nepal], January 15 (ANI): After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track.
Read More
Nepal approves emergency use of Covishield vaccine
Updated : 5 years, 4 months ago IST
Kathmandu [Nepal], January 15 (ANI): Nepal Government on Friday approved the emergency use of 'Covishield' vaccine, which is being manufactured by the Serum Institute of India (SII).
Read More
Indians are not guinea pigs, you can't use Covaxin rollout as phase 3 tria
Updated : 5 years, 4 months ago IST
New Delhi [India], January 14 (ANI): Congress leader Manish Tewari on Wednesday said that emergency use authorization to COVID-19 vaccine 'Covaxin' raises concerns on its efficacy as phase three trials have not been completed and its roll out can't be used as phase three trial. He said India
Read More
Covishield, Covaxin are safest of COVID-19 vaccines, side-effects are neg
Updated : 5 years, 4 months ago IST
New Delhi [India], January 12 (ANI): Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the
Read More
COVID-19 vaccine may cost between Rs 200 to 295 in India: Health Ministry
Updated : 5 years, 4 months ago IST
New Delhi [India], January 12 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said the COVID-19 vaccine may cost in the range of Rs 200 to 295 in India and two vaccines -- Covishield and Covaxin -- have received Emergency Use Authorisation (EAU) after going through established saf
Read More
Bolivia registers Sputnik V vaccine for emergency use authorisation
Updated : 5 years, 4 months ago IST
Moscow [Russia], January 7 (ANI): The Russian Direct Investment Fund (RDIF) on Wednesday announced that Bolivia's State Agency for Medicines and Health Technologies has registered Sputnik V Covid-19 vaccine under emergency use authorisation procedure.
Read More
Emergency use of vaccine is based on safety, immunogenicity data, says ICM
Updated : 5 years, 4 months ago IST
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
Read More
India prepared to roll out COVID-19 vaccine within 10 days of emergency us
Updated : 5 years, 4 months ago IST
New Delhi [India], January 5 (ANI): Days after Drugs Controller General of India (DCGI) gave approval to two COVID-19 vaccines, Union Health Secretary Rajesh Bhushan on Tuesday said that India is prepared to roll out vaccine within 10 days of emergency use authorisation (EUA), subject to
Read More
Our goal is to provide global access of Covaxin to needy population: Dr E
Updated : 5 years, 4 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
Read More
Unseemly haste risks jeopardising India's good reputation: Shashi Tharoor
Updated : 5 years, 4 months ago IST
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
Read More